Kevin Clarke, MD
Surgical Oncology · Newark, NJNPI 1598789265
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (44.8%), travel and lodging and education — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Intuitive Surgical at 59.4% of the total. Reporting peaked in 2022 at $2,112 and has fallen 57.9% since, to $889 in 2025.
Across 72 payments — averaging $81.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$3K
- Axogen$975
- Convatec Inc.$291
- Smith+Nephew$255
- Dilon Technologies, Inc.$149
- Baxter Healthcare$117
- plus $596 from 14 others
What the payments were for
- Travel & lodging$2,22338%
- Food & beverage$2,62945%
- Education$1,00017%
- Gifts$140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 17 | $3,483 |
| Axogen | 6 | $975 |
| Convatec Inc. | 5 | $291 |
| Smith+Nephew | 17 | $255 |
| Dilon Technologies, Inc. | 1 | $149 |
| Baxter Healthcare | 1 | $117 |
| Johnson & Johnson | 4 | $97 |
| Merck | 5 | $94 |
| E.r. Squibb & Sons, L.L.C. | 1 | $88 |
| KCI USA, Inc. | 3 | $83 |
| Solventum Corporation | 2 | $52 |
| Pacira Pharmaceuticals Incorporated | 2 | $31 |
| Next Science LLC | 1 | $28 |
| Avanos Medical | 1 | $26 |
| Lilly USA, LLC | 1 | $19 |
| Daiichi Sankyo Inc. | 1 | $18 |
| Bristol Myers Squibb | 1 | $17 |
| W. L. Gore & Associates, Inc. | 1 | $15 |
| Davol Inc. | 1 | $14 |
| Intra-sana Laboratories | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$3,258
- AVANCE NERVE GRAFT$925
- AxoGuard Nerve Connector$925
- AxoGuard Nerve Protector$925
- AXOGUARD HA+ NERVE PROTECTOR$925
- AxoGuard Nerve Cap$925
- HemoBlast Bellows$149
- InnovaMatrix AC$117
- FLOSEAL$117
- AQUACEL Foam Pro$101
- AQUACEL Ag Extra$101
How this compares
$5,866 in reported general payments places this provider in the 75th percentile of 59 surgical oncology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 13 | $91 |
Paid to pharmacies, not to this prescriber.
Other surgical oncology in Newark
- Ravi ChokshiNewark$1K
- Ogori KaluNewark$376
- Maria Elena BenjaminNewark$23
- Thangamani SeenivasanSomerville$22K
- John CunninghamBerkeley Heights$20K
- Manpreet KohliLong Branch$20K
- Haejin InNew Brunswick$12K
- Anjeanette BrownCape May Court House$11K
- Marc FromerBrick$9K
- Russell LanganLivingston$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.